• Je něco špatně v tomto záznamu ?

Red palm oil supplementation does not increase blood glucose or serum lipids levels in Wistar rats with different thyroid status

H. Rauchová, M. Vokurková, S. Pavelka, I. Vaněčková, N. Tribulová, T. Soukup

. 2018 ; 67 (2) : 307-315. [pub] 20180105

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18036406

Grantová podpora
NV15-25396A MZ0 CEP - Centrální evidence projektů

Red palm oil (RPO) is a rich natural source of antioxidant vitamins, namely carotenes, tocopherols and tocotrienols. However, it contains approximately 50 % saturated fatty acids the regular consumption of which could negatively modify lipid profile. The aim of our study was to test whether 7 weeks of RPO supplementation (1 g/kg body weight/day) would affect blood glucose and lipid metabolism in adult male Wistar rats with altered thyroid status. We induced hypothyroidism and hyperthyroidism in rats by oral administration of either methimazole or mixture of thyroid hormones. Different thyroid status (EU - euthyroid, HY - hypothyroid and HT - hyperthyroid) was characterized by different serum thyroid hormones levels (total and free thyroxine and triiodothyronine), changes in the activity of a marker enzyme of thyroid status - liver mitochondrial glycerol-3-phosphate dehydrogenase, and altered absolute and relative heart weights. Fasting blood glucose levels were higher in HT rats in comparison with EU and HY rats, but the changes caused by RPO supplementation were not significant. The achievement of the HY status significantly increased serum levels of total cholesterol, as well as with high-density lipoprotein-cholesterol and low-density lipoprotein-cholesterol: 2.43+/-0.15, 1.48+/-0.09, 0.89+/-0.08 mmol/l, compared to EU: 1.14+/-0.06, 0.77+/-0.06, 0.34+/-0.05 mmol/l and HT: 1.01+/-0.06, 0.69+/-0.04, 0.20+/-0.03 mmol/l, respectively. RPO supplementation did not increase significantly levels of blood lipids but tended to increase glutathione levels in the liver. In conclusion, RPO supplementation did not induce the presumed deterioration of glucose and lipid metabolism in rats with three well-characterized alterations in thyroid status.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18036406
003      
CZ-PrNML
005      
20181102123637.0
007      
ta
008      
181030s2018 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933834 $2 doi
035    __
$a (PubMed)29303614
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Rauchová, Hana, $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic $d 1950- $7 xx0074209
245    10
$a Red palm oil supplementation does not increase blood glucose or serum lipids levels in Wistar rats with different thyroid status / $c H. Rauchová, M. Vokurková, S. Pavelka, I. Vaněčková, N. Tribulová, T. Soukup
520    9_
$a Red palm oil (RPO) is a rich natural source of antioxidant vitamins, namely carotenes, tocopherols and tocotrienols. However, it contains approximately 50 % saturated fatty acids the regular consumption of which could negatively modify lipid profile. The aim of our study was to test whether 7 weeks of RPO supplementation (1 g/kg body weight/day) would affect blood glucose and lipid metabolism in adult male Wistar rats with altered thyroid status. We induced hypothyroidism and hyperthyroidism in rats by oral administration of either methimazole or mixture of thyroid hormones. Different thyroid status (EU - euthyroid, HY - hypothyroid and HT - hyperthyroid) was characterized by different serum thyroid hormones levels (total and free thyroxine and triiodothyronine), changes in the activity of a marker enzyme of thyroid status - liver mitochondrial glycerol-3-phosphate dehydrogenase, and altered absolute and relative heart weights. Fasting blood glucose levels were higher in HT rats in comparison with EU and HY rats, but the changes caused by RPO supplementation were not significant. The achievement of the HY status significantly increased serum levels of total cholesterol, as well as with high-density lipoprotein-cholesterol and low-density lipoprotein-cholesterol: 2.43+/-0.15, 1.48+/-0.09, 0.89+/-0.08 mmol/l, compared to EU: 1.14+/-0.06, 0.77+/-0.06, 0.34+/-0.05 mmol/l and HT: 1.01+/-0.06, 0.69+/-0.04, 0.20+/-0.03 mmol/l, respectively. RPO supplementation did not increase significantly levels of blood lipids but tended to increase glutathione levels in the liver. In conclusion, RPO supplementation did not induce the presumed deterioration of glucose and lipid metabolism in rats with three well-characterized alterations in thyroid status.
650    _2
$a zvířata $7 D000818
650    _2
$a krevní glukóza $x metabolismus $7 D001786
650    _2
$a tělesná hmotnost $x účinky léků $7 D001835
650    12
$a potravní doplňky $7 D019587
650    _2
$a glutathion $x metabolismus $7 D005978
650    _2
$a hypertyreóza $x metabolismus $7 D006980
650    _2
$a hypotyreóza $x metabolismus $7 D007037
650    _2
$a ledviny $x účinky léků $x metabolismus $7 D007668
650    _2
$a lipidy $x krev $7 D008055
650    _2
$a játra $x účinky léků $x metabolismus $7 D008099
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a jaterní mitochondrie $x účinky léků $x metabolismus $7 D008930
650    _2
$a velikost orgánu $x účinky léků $7 D009929
650    _2
$a palmový olej $x farmakologie $7 D000073878
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a štítná žláza $x metabolismus $7 D013961
650    _2
$a hormony štítné žlázy $x krev $7 D013963
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vokurková, Martina, $d 1973- $7 xx0037678 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Pavelka, Stanislav, $d 1949- $7 xx0093081 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vaněčková, Ivana, $d 1964- $7 xx0030586 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Tribulová, Narcisa, $d 1946- $7 xx0104473 $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
700    1_
$a Soukup, Tomáš $7 xx0140789 $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, č. 2 (2018), s. 307-315
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29303614 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20181030 $b ABA008
991    __
$a 20181102103444 $b ABA008
999    __
$a ok $b bmc $g 1347829 $s 1033430
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 67 $c 2 $d 307-315 $e 20180105 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
GRA    __
$a NV15-25396A $p MZ0
LZP    __
$b NLK118 $a Pubmed-20181030

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...